Imperial College Business School : [1626] Collection home page

Browse
Collection's Items (Sorted by Title in Ascending order): 201 to 220 of 1626
Issue DateTitleAuthor(s)
1-Jul-2023Building a competitive advantage based on transparency: when and why does transparency matter for corporate social responsibility?Liu, Y; Heinberg, M; Huang, X; Eisingerich, A
21-Apr-2017Building an empire with relationshipsEisingerich, AB; Vatter, Z
1-Oct-1999Building governance institutions across European bordersPerkmann, M
Jan-2011Building theory about theory building: what constitutes a theoretical contribution?Corley, KG; Gioia, DA
Jun-2022Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019Armocida, B; Monasta, L; Sawyer, S; Bustreo, F; Segafredo, G, et al
2021Business model design and ecosystem Iinnovation: a method for visualizing interactionsGlassey-Previdoli, D; Bonazzi, R; Viscusi, G
8-Oct-2022Business models for active buildingsElliott, T; Geske, J; Green, R;
1-Apr-2022Busy academics share less: the impact of professional and family roles on academic withholding behaviourDefazio, D; Kolympiris, C; Perkmann, M; Salter, A;
-Buy now pay later: impact of installment payments on customer purchasesMaesen, S; Ang, D
16-Jun-2020Buyer's optimal information revelation strategy in procurement auctionsQian, C; Anderson, E
8-Dec-2019Calculating optimistic likelihoods using (geodesically) convex optimizationNguyen, VA; Shafieezadeh-Abadeh, S; Yue, MC; Kuhn, D; Wiesemann, W
2-Oct-2014Calling circles: Network competition with non-uniform calling patternsValletti, T; Inderst, R; Hoernig, S
1-Aug-2021Can alliance substitute acquisition? the evidence from natural experimentLee, J; Lee, JM
1-Dec-2008Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent moleculesGonzalez, J; Sismeiro, C; Dutta, S; Stern, P
Jan-2012Can governments do it better? Merger mania and hospital outcomes in the English NHSPropper, C; Laudicella, M; Gaynor, M
17-May-2013Can intangible investment explain the UK productivity puzzle?Haskel, J; Goodridge, P; Wallis, G
31-Dec-2012Can overpricing of technology stocks be good for welfare? Positive spillovers vs. equity market lossesTinn, K; Vourvachaki, E
1-Apr-2015"Can Regulators Allow Banks to Set their Own Capital Ratios?"Cathcart, L; El-Jahel, L; Jabbour, R
Mar-2017Can retail sales volatility be curbed through marketing actions?Esteban-Bravo, M; Vidal-Sanz, JM; Yildirim, G
1-Sep-2012Can the Life Insurance Market Provide Evidence for a Bequest Motive?Inkmann, J; Michaelides, A
Collection's Items (Sorted by Title in Ascending order): 201 to 220 of 1626